Respiratory Dis. Ctr on Muck Rack

Respiratory Dis. Ctr

As seen in: The Journal of Allergy & Clinical Immunology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Respiratory Dis.

Contact Respiratory Dis., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Biologic Outcomes Among US Subspecialist-treated Adults with Severe Asthma and Allergic Disease: Results from the CHRONICLE Study

|
By Asthma Associates, Bradley Chipps, Respiratory Dis. Ctr, Reynold A. Panettieri
| The Journal of Allergy & Clinical Immunology Verified
Biologic therapies can improve outcomes for patients with severe asthma (SA). Based on the mechanisms of approved biologics, outcomes could vary by type of biologic (e.g., anti-IgE versus other) in patients with allergic disease. We examined exacerbation rates before and after biologic initiation among US subspecialist-treated adults with SA and diagnosed allergic rhinitis.
Open in Who Shared Issue with article?

Asthma Impairment and Risk Questionnaire (AIRQ®) Score Predicts Risk for Multiple Exacerbations Among Patients with Very Poorly Controlled Disease

|
By Kevin Murphy, Bradley Chipps, Respiratory Dis. Ctr, David Beuther
| The Journal of Allergy & Clinical Immunology Verified
The Asthma Impairment and Risk Questionnaire (AIRQ®) is a 10-item, yes/no, control tool with scores of 0-1, 2-4, and 5-10 yes responses for well-controlled (WC), not well-controlled (NWC), and very poorly controlled (VPC) asthma, respectively. To determine whether scores 5-10 can differentiate risk levels for multiple exacerbations within the next 12 months in VPC patients, the predictive performance of AIRQ® was analyzed.
Open in Who Shared Issue with article?

The Asthma Impairment and Risk Questionnaire (AIRQ®) Predicts Short- and Long-term Risk of Exacerbations in Adolescents and Adults with Asthma

|
By William McCann, Bradley Chipps, Respiratory Dis. Ctr, David Beuther
| The Journal of Allergy & Clinical Immunology Verified
Asthma Impairment and Risk Questionnaire (AIRQ®) Score Predicts Risk for Multiple Exacerbations Among Patients with Very Poorly Controlled Disease
Open in Who Shared Issue with article?
See all 4 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified